| Item Type | Name |
|
Concept
|
Receptors, Antigen, B-Cell
|
|
Concept
|
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor
|
|
Concept
|
Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor
|
|
Concept
|
Receptors, Colony-Stimulating Factor
|
|
Concept
|
Receptors, Interleukin-2
|
|
Concept
|
Receptors, Antigen, T-Cell, alpha-beta
|
|
Concept
|
Interferon-alpha
|
|
Concept
|
Receptors, Interferon
|
|
Concept
|
Receptor Protein-Tyrosine Kinases
|
|
Concept
|
Receptor, Platelet-Derived Growth Factor alpha
|
|
Concept
|
Core Binding Factor Alpha 2 Subunit
|
|
Concept
|
Receptors, Antigen, T-Cell
|
|
Concept
|
fas Receptor
|
|
Concept
|
Receptor, Platelet-Derived Growth Factor beta
|
|
Academic Article
|
Acute myeloid leukaemia following interferon-alfa treatment of hairy cell leukaemia.
|
|
Academic Article
|
Expression of the IFN alpha receptor in hairy cell leukaemia.
|
|
Academic Article
|
Diagnostic criteria and classification of mastocytosis: a consensus proposal.
|
|
Academic Article
|
Serum soluble interleukin-2 receptor is associated with clinical and pathologic disease status in hairy cell leukemia.
|
|
Academic Article
|
Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia.
|
|
Academic Article
|
Alpha-2 interferon therapy of hairy-cell leukemia: a multicenter study of 64 patients.
|
|
Academic Article
|
Changes in peripheral blood and bone marrow specimens following therapy with recombinant alpha 2 interferon for hairy cell leukemia.
|
|
Academic Article
|
Treatment of hairy cell leukemia with recombinant alpha 2 interferon.
|
|
Academic Article
|
Relapse after interferon alfa-2b therapy for hairy-cell leukemia: analysis of prognostic variables.
|
|
Academic Article
|
Surface immunoglobulin, lectin-induced cap formation, and phagocytic function in five patients with the leukemic phase of hairy cell leukemia.
|
|
Academic Article
|
Surface immunoglobulins on hairy cells of 55 patients with hairy cell leukemia.
|
|
Academic Article
|
Complex rearrangement of the T cell receptor in large granular lymphocytosis associated with myeloid suppression.
|
|
Academic Article
|
Phase I trial of a genetically engineered interleukin-2 fusion toxin (DAB486IL-2) as a 6 hour intravenous infusion in patients with hematologic malignancies.
|
|
Academic Article
|
Changes in peripheral blood and bone marrow specimens during and after alpha 2b-interferon therapy for hairy cell leukemia.
|
|
Academic Article
|
Increased incidence of second neoplasms in patients treated with interferon alpha 2b for hairy cell leukemia: a clinicopathologic assessment.
|
|
Academic Article
|
Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics.
|
|
Academic Article
|
Low-dose interferon alfa-2b in the treatment of hairy cell leukemia.
|
|
Academic Article
|
miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia.
|
|
Academic Article
|
Prognostic significance of immunologic phenotype in hairy cell leukemia: does it exist?
|
|
Academic Article
|
Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a Cancer and Leukemia Group B Study.
|
|
Academic Article
|
Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B study.
|
|
Academic Article
|
Core binding factor acute myeloid leukemia. Cancer and Leukemia Group B (CALGB) Study 8461.
|
|
Academic Article
|
Hairy cell leukaemia: evidence for the existence of a spectrum of functional characteristics.
|
|
Academic Article
|
PLZF staining identifies peripheral T-cell lymphomas derived from innate-like T-cells with TRAV1-2-TRAJ33 TCR-a rearrangement.
|